Publications by authors named "Forti Lujan"

Claim this Profile
A
A study to assess the unmet medical needs associated with the use of basal insulin in patients with type 2 diabetes.
Gustavo Frechtel, Lujan Forti, Cristina Faingold, Federico Perez Mangui, Silvia Orio

Endocrinol Diabetes Metab· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treat-to-target HbA and lipid profile to prolong β-cell mass/function and optimize treatment goal attainment.
Juan J Gagliardino, Jorge Elgart, Luján Forti, María Silvina Guaita, Jean M Chantelot

Diabetes Metab Res Rev· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[New generation of insulins: glargine U300. Summary of clinical evidence].
Carla Musso, Lina Capurro, Evelin Mingote, Luján Forti, María Silvina Guaita

Medicina (B Aires)· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type 2 diabetes: Prescription patterns and treatment outcomes of IDMPS survey in Argentina.
Gagliardino Juan José, Elgart Jorge, Forti Lujan, Querzoli Ivanna, Chantelot Jean-Marc

Diabetes Res Clin Pract· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Update on the diagnosis of diabetes].
Mariano Benzadón, Luján Forti, Isaac Sinay

Medicina (B Aires)· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adding ivabradine may reduce elevated heart rate in acute patients when β blockers are ineffective.
Marcelo Trivi, Lujan Forti, Diego Conde, Mirta Diez

Am J Emerg Med· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis